Home > Cashflow Statement > MEDICAMEN BIOTECH

MEDICAMEN BIOTECH
Cash Flow from Operating Activities

    Back to Cashflow Statement
MEDICAMEN BIOTECH is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for MEDICAMEN BIOTECH
Please provide your vote to see the results

MEDICAMEN BIOTECH Last 5 Year Cash Flow from Operating Activities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Cash Flow from Operating Activities ₹-6.74 Cr₹-6.29 Cr₹4.11 Cr₹13 Cr₹13 Cr

What is the latest Cash Flow from Operating Activities ratio of MEDICAMEN BIOTECH ?

The latest Cash Flow from Operating Activities ratio of MEDICAMEN BIOTECH is ₹-6.74 Cr based on Mar2024 Consolidated results.
Year Cash Flow from Operating Activities
Mar2024₹-6.74 Cr
Mar2023₹-6.29 Cr
Mar2022₹4.11 Cr
Mar2021₹13 Cr
Mar2020₹13 Cr

How is Cash Flow from Operating Activities of MEDICAMEN BIOTECH Trending?

Years Cash Flow from Operating Activities % Change
Mar2024 ₹-6.74 Cr
Negative
Mar2023 ₹-6.29 Cr
Negative
Mar2022 ₹4.11 Cr
-67.83
Mar2021 ₹13 Cr
-0.23
Mar2020 ₹13 Cr -

Compare Cash Flow from Operating Activities of peers of MEDICAMEN BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH ₹549.7 Cr 5.3% -0.9% -13.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,267.0 Cr 0.7% 2.8% 7.9% Stock Analytics
DIVIS LABORATORIES ₹178,672.0 Cr -0.8% 3.7% 48.6% Stock Analytics
CIPLA ₹119,713.0 Cr -0.2% -0.1% -1.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹119,195.0 Cr 3.4% 11.2% 17.9% Stock Analytics
DR REDDYS LABORATORIES ₹104,999.0 Cr 0.6% -5.2% -4.9% Stock Analytics


MEDICAMEN BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH

5.3%

-0.9%

-13.3%

SENSEX

-0.9%

0.4%

1.4%


You may also like the below Video Courses